| Literature DB >> 32012720 |
Sunga Kong1,2, Hye Yun Park3, Danbee Kang1,4, Jae Kyung Lee2, Genehee Lee2, O Jung Kwon3, Young Mog Shim5, Jae Ill Zo5, Juhee Cho1,4,6.
Abstract
We aim to examine how season and temperature levels affect physical activity using a wearable device among patients scheduled to undergo surgical resection of lung cancer. Physical activity (PA) data from the wearable device were analyzed by seasons for 555 preoperative lung cancer patients from the CATCH-LUNG cohort study. The seasons were divided into spring, summer, autumn, and winter using the study enrollment date before surgery. The overall mean (SD) age was 61.1 (8.9) years, and the mean (SD) daily steps at each season were 11,438 (5922), 11,147 (5065), 10,404 (4403), and 8548 (4293), respectively. In the fully-adjusted models, patients in the winter season had 27.04% fewer daily steps (95% CI = -36.68%, -15.93%) and 35.22% less time spent performing moderate to vigorous physical activity (MVPA) compared to patients in the spring. The proportion of participants with over 8000 steps and duration of MVPA were significantly lower in the winter than the spring. In particular, daily steps had a negative linear association with wind chill temperature in patients who lived in Seoul. In conclusion, PA was significantly lower in the winter and it was more robust in patients who had a low cardiorespiratory function.Entities:
Keywords: lung cancer; physical activity; preoperative; season; wearable
Year: 2020 PMID: 32012720 PMCID: PMC7073689 DOI: 10.3390/jcm9020349
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Characteristics of study participants by season (n = 555).
| Characteristics | Spring | Summer | Autumn | Winter |
|
|---|---|---|---|---|---|
|
| 60.6 (8.9) | 62.6 (8.3) | 60.6 (9.0) | 59.9 (9.4) | 0.05 |
|
| 0.04 | ||||
| <65 | 118 (69.0) | 104 (58.4) | 66 (66.7) | 79 (73.8) | |
| ≥65 | 53 (31.0) | 74 (41.6) | 33 (33.3) | 28 (26.2) | |
|
| 97 (56.7) | 101 (56.7) | 57 (57.6) | 57 (53.3) | 0.92 |
|
| 24.1 (2.9) | 24.3 (2.7) | 24.1 (2.7) | 24.5 (3.2) | 0.67 |
|
| 0.32 | ||||
| Never-smoker | 78 (45.6) | 89 (50.0) | 48 (48.5) | 57 (53.3) | |
| Ex-smoker | 59 (34.5) | 34 (19.1) | 27 (27.3) | 16 (15.0) | |
| Current smoker | 34 (19.9) | 55 (30.9) | 24 (24.2) | 34 (31.8) | |
|
| 0.64 | ||||
| Married | 151 (88.3) | 159 (89.3) | 91 (91.9) | 91 (85.1) | |
| Single/divorced/widowed | 19 (11.1) | 19 (10.7) | 7 (7.1) | 15 (14.0) | |
| Unknown | 1 (0.6) | 0 | 1 (1.0) | 1 (0.9) | |
|
| 0.46 | ||||
| Current work | 98 (57.3) | 81 (45.5) | 49 (49.5) | 58 (54.2) | |
| No work | 72 (42.1) | 96 (53.9) | 49 (49.5) | 48 (44.9) | |
| Unknown | 1 (0.6) | 1 (0.6) | 1 (1.0) | 1 (0.9) | |
|
| 0.19 | ||||
| <$3.000 | 54 (31.6) | 51 (28.7) | 23 (23.2) | 31 (29.0) | |
| ≥$3.000 | 87 (50.9) | 93 (52.3) | 54 (54.6) | 66 (61.7) | |
| Unknown | 30 (17.5) | 34 (19.1) | 22 (22.2) | 10 (9.4) | |
|
| |||||
|
| |||||
| COPD | 40 (23.4) | 43 (24.2) | 26 (26.3) | 19 (17.8) | 0.49 |
| Asthma | 3 (1.8) | 8 (4.5) | 1 (1.0) | 3 (2.8) | 0.34 |
| ILD | 1 (0.6) | 2 (1.1) | 1 (1.0) | 2 (1.9) | 0.86 |
|
| |||||
| Hypertension | 52 (30.4) | 72 (40.5) | 28 (28.3) | 35 (32.7) | 0.12 |
| Diabetes mellitus | 22 (12.9) | 27 (15.2) | 11 (11.1) | 7 (6.5) | 0.18 |
| Cardiovascular disease | 12 (7.0) | 20 (11.2) | 9 (9.1) | 9 (8.4) | 0.58 |
|
| 0.81 | ||||
| I | 128 (74.9) | 130 (73.0) | 75 (75.8) | 75 (70.1) | |
| II | 25 (14.6) | 31 (17.4) | 13 (13.1) | 16 (15.0) | |
| III | 18 (10.5) | 17 (9.6) | 11 (11.1) | 16 (15.0) | |
|
| |||||
| FVC, L | 3.6 (0.9) | 3.4 (0.8) | 3.7 (0.9) | 3.7 (0.8) | 0.02 |
| FVC, % predicted | 93.4 (11.5) | 89.8 (12.9) | 94.3 (12.7) | 96.4 (12.1) | < 0.01 |
| FEV1, L | 2.7 (0.7) | 2.5 (0.6) | 2.7 (0.6) | 2.8 (0.6) | < 0.01 |
| FEV1, % predicted | 90.0 (13.2) | 87.5 (15.5) | 90.2 (14.9) | 95.0 (13.5) | < 0.01 |
| FEV1/FVC | 73.8 (8.2) | 73.6 (8.6) | 72.6 (8.6) | 75.1 (8.3) | 0.21 |
| DLco, % | 91.6 (16.0) | 89.2 (17.3) | 89.7 (15.2) | 91.3 (13.7) | 0.47 |
|
| |||||
| 6 min walk distance (m) | 520.1(85.7) | 506.9(89.1) | 515.0(66.8) | 508.1(80.7) | 0.46 |
| 6 min walk distance | 0.69 | ||||
| Short distance (<500 m) | 68 (39.9) | 77 (43.3) | 37 (37.4) | 49 (45.8) | |
| Long distance (≥500 m) | 102 (59.7) | 97 (54.5) | 60 (60.1) | 56 (52.3) | |
| Unknown | 1 (0.6) | 4 (2.3) | 2 (2.1) | 2 (1.9) |
Values are presented as either n (%) or mean (SD). COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; DLco, diffusing capacity of carbon monoxide.
Figure 1Mean daily steps and the proportion of participants who had more than 8000 steps in each season.
Differences in physical activity by season.
| Spring | Summer | Autumn | Winter | |
|---|---|---|---|---|
|
| ||||
|
| Reference | −0.86 (−12.38, 12.18) | −6.24 (−18.86, 8.33) | −27.04 (−36.68, −15.93) |
|
| ||||
| <65 years | Reference | −8.08 (−21.25, 7.30) | −10.27 (−24.74, 6.98) | −25.21 (−36.65, −11.70) |
| ≥65 years | Reference | 11.91 (−9.08, 37.74) | 2.36 (−20.65, 32.02) | −32.16 (−48.31, −10.97) |
| 0.14 | 0.40 | 0.55 | ||
|
| ||||
| <500 m | Reference | −1.21 (−18.1, 19.18) | 7.07 (−14.97, 34.83) | −27.63 (−41.48, −10.50) |
| ≥500 m | Reference | −0.75 (−15.53, 16.62) | −12.95 (−27.52, 4.55) | −20.97 (−34.54, −4.59) |
| 0.97 | 0.17 | 0.54 | ||
|
| ||||
|
| Reference | 5.06 (−14.6, 29.24) | −2.11(−23.13, 24.67) | −35.22 (−49.18, −17.43) |
|
| ||||
| <65 years | Reference | 5.13 (−19.26, 36.89) | −1.43 (−26.71, 32.57) | −33.03 (−49.63, −10.95) |
| ≥65 years | Reference | 4.05 (−26.37, 47.04) | −3.75 (−37.24, 47.60) | −40.72 (−62.76, −5.62) |
| 0.96 | 0.93 | 0.66 | ||
|
| ||||
| <500 m | Reference | −4.25 (−30.56, 32.04) | 20.57 (−18.5, 78.39) | −38.65 (−57.62, −11.18) |
| ≥500 m | Reference | 11.12 (−15.17, 45.55) | −10.57 (−34.3, 21.73) | −26.01 (−46.46, 2.25) |
| 0.48 | 0.24 | 0.03 | ||
Models were adjusted for age, sex, smoking status, FEV1% pred, any pulmonary comorbidities, and any extra-pulmonary comorbidities. Pulmonary comorbidities include chronic obstructive pulmonary disease, asthma, or interstitial lung disease, and extra-pulmonary comorbidities include cardiovascular diseases or diabetes mellitus. 6MWD, 6-min walk distance. MVPA, moderate-to-vigorous physical activity.
Odds ratios (95% CI) for physical activity by season.
| Spring | Summer | Autumn | Winter | |
|---|---|---|---|---|
|
| ||||
|
| Reference | 1.11 (0.69, 1.79) | 0.98 (0.57, 1.70) | 0.46 (0.28, 0.77) |
|
| ||||
| <65 years | Reference | 0.79 (0.43, 1.44) | 0.73 (0.37, 1.45) | 0.38 (0.20, 0.71) |
| ≥65 years | Reference | 2.00 (0.93, 4.31) | 1.75 (0.67, 4.56) | 0.67 (0.26, 1.74) |
| 0.06 | 0.15 | 0.32 | ||
|
| ||||
| <500 m | Reference | 0.94 (0.48, 1.82) | 1.75 (0.73, 4.20) | 0.45 (0.21, 0.96) |
| ≥500 m | Reference | 1.35 (0.67, 2.74) | 0.74 (0.36, 1.55) | 0.58 (0.28, 1.22) |
| 0.46 | 0.14 | 0.63 | ||
|
| ||||
|
| Reference | 1.73 (1.10, 2.71) | 1.07 (0.62, 1.83) | 0.52 (0.29, 0.94) |
|
| ||||
| <65 years | Reference | 1.59 (0.91, 2.79) | 1.19 (0.62, 2.27) | 0.59 (0.30, 1.15) |
| ≥65 years | Reference | 2.11 (0.96, 4.61) | 0.92 (0.34, 2.50) | 0.29 (0.07, 1.13) |
| P for interaction | 0.50 | 0.72 | 0.42 | |
|
| ||||
| <500 m | Reference | 1.26 (0.61, 2.58) | 1.24 (0.52, 2.98) | 0.30 (0.10, 0.87) |
| ≥500 m | Reference | 1.97 (1.10, 3.55) | 1.03 (0.52, 2.05) | 0.77 (0.37, 1.61) |
| 0.34 | 0.75 | 0.15 |
Models were adjusted for age, sex, smoking status, FEV1% pred, any pulmonary comorbidities, and any extra-pulmonary comorbidities. Pulmonary comorbidities include chronic obstructive pulmonary disease, asthma, or interstitial lung disease, and extra-pulmonary comorbidities include cardiovascular diseases or diabetes mellitus. 6MWD, 6-min walk distance. MVPA, moderate-to-vigorous physical activity.
Figure 2Mean daily steps (95% CI) by wind chill temperature. The curves represent daily step (solid line) and their 95% confidence intervals (dashed lines) based on restricted cubic splines for wind chill temperature with knots at the 5th, 35th, 65th, and 95th percentiles of their sample distributions. The reference value (diamond dot) was set at the 90th percentile.